A study published in Archives of Ophthalmology found that high-altitude climbers experience corneal swelling, but their vision remains unaffected at elevations of up to 20,670 feet. The authors suggest that oxygen levels may play a crucial role in maintaining corneal health.
A virtual training tool enhances teaching in cataract surgery, improving resident performance and patient outcomes. The Massachusetts Eye and Ear Infirmary Cataract Surgery Trainer allows residents to practice complex surgeries in a safe, simulated environment.
A recent study by Kaiser Permanente has compared the effectiveness of two AMD drugs, ranibizumab (Lucentis) and bevacizumab (Avastin), while a global report highlights retinal vein occlusion prevalence worldwide. Additionally, research reveals that central vision impairment significantly increases the risk of falls in older adults.
A new tool called PEG-POD significantly increases gene delivery to retinal cells, outperforming existing carriers and DNA alone. This breakthrough may help develop therapies for conditions like retinitis pigmentosa and age-related macular degeneration.
A new study found that UV-blocking contact lenses can reduce or eliminate the effects of the sun's harmful UV radiation. The lenses, such as Senofilcon A, provide an additional layer of protection against UV-induced damage to the cornea and lens, including cataracts.
A new predictor of cornea transplant success has been identified by the Cornea Donor Study Investigator Group. The study found that a patient's endothelial cell count six months post-transplant is a better indicator of subsequent failure of the graft rather than the donor's cell count.
Researchers reviewed the effects of Vitamins C and E and magnesium on diabetic retinopathy, finding no strong evidence to support their use as supplements. Ethnic norms were established for preschoolers' eyesight, revealing higher rates of myopia in African-American children compared to Hispanic children.
A UCLA study published in the American Journal of Ophthalmology found that older women who quit smoking had a significantly lower risk of developing advanced age-related macular degeneration. The research, led by Dr. Anne Coleman, followed 1,958 women over five years and showed that even after age 80, quitting smoking can reduce AMD risk.
Researchers found that injecting triamcinolone into the eye may slow proliferative diabetic retinopathy progression, but not macular edema. Steroid treatments reduced the risk of retinopathy progression without significantly improving vision outcomes.
Researchers at the University of Iowa have found a new inherited retinal disease affecting the macula, which is an area critical for central vision. The disease causes abnormal blood vessels to form, leading to swelling or scars that can blur parts of the visual field.
Researchers have found that transplanting human umbilical mesenchymal stem cells into mouse models can restore transparency to cloudy and thin corneas. The stem cells can survive in the stroma for over three months without rejection and become functional corneal cells.
A study emphasizes the need for dedicated management capacity to address blindness in sub-Saharan Africa. The region has 20% of global blindness despite having only 11% of the world's population, highlighting the importance of effective management systems.
A recent study found that low-dose aspirin may offer mild protection from AMD, reducing the risk by 18% in women who took the medication. However, statins did not show a significant impact on advanced AMD risk, with patients taking statins actually at a slightly higher risk of developing advanced disease.
Researchers at Yale University have identified a novel protective mechanism in photoreceptors that could help preserve vision in people with eye diseases. The study found that the activation of CREB1/ATF1 is part of this pathway, which was triggered by stress and can be activated by certain drugs.
A small group of patients with severe Graves' eye disease showed rapid improvement after treatment with rituximab, reducing inflammation and optic nerve damage. The study suggests that rituximab may offer sustained benefits as an alternative to high-dose steroids.
A national study found cataract surgery benefits AMD patients at all stages of the disease, improving vision in those with mild to advanced AMD. Steroid triamcinolone also showed promise in treating advanced DME, with improved vision in patients whose eyes had deteriorated despite standard treatment.
Dr. H. Dwight Cavanagh, a renowned UT Southwestern ophthalmologist, has been awarded the Cornea Society's highest honor, the Castroviejo Medal. His groundbreaking research on corneal biology and transplantation has improved treatments for eye diseases.
Physician-researchers at USC have received a nearly $16 million grant to develop a stem cell-based treatment for age-related macular degeneration. The four-year study aims to replace damaged retinal cells with healthy ones derived from human embryonic stem cells.
A recent study found that Iraq and Afghanistan veterans with TBI vision loss have significantly poorer quality of life than comparable civilians. Low-vision patients may also experience vivid visual hallucinations due to Charles Bonnet syndrome, which can be treated by ignoring the images or medication.
Dr. Michael W. Brennan leads a team of American physicians working with Iraqi physicians to provide improved care as the country recovers from war traumas. He has been instrumental in developing a national emergency medical system and mental health programs, transforming Iraq's medical education and patient care.
Researchers found that implantation of blue light-filtering IOLs at cataract surgery increased macular pigment levels, which may offer protection against age-related macular degeneration. The study suggests a strong scientific rationale for the benefits of blue light-filtering in reducing vision loss.
A study found that anti-VEGF treatment for wet age-related macular degeneration can lead to increased intraocular pressure in patients without a family history of glaucoma. A new low-cost vision screening method, using an auto-refractor and pre-made eyeglasses, has shown promise in improving vision for millions in developing countries.
Glaucoma clinics face challenges in providing follow-up care to patients from diverse ethnic backgrounds, with long wait times and interpreter issues cited as major barriers. To address these issues, researchers suggest streamlining appointment procedures and resolving wait time and language obstacles.
Studies suggest ophthalmologists should suspect visual variant Alzheimer's in patients with unusual or severe vision problems, particularly difficulty reading. Nearsighted individuals may be less susceptible to diabetic retinopathy due to reduced risks associated with longer axial length and deeper anterior eye chamber.
Gene therapy has been shown to improve vision in children with Leber congenital amaurosis, a severe form of inherited retinal degeneration. The treatment resulted in significant improvements in both subjective and objective measurements of vision.
Researchers found that brains can be trained to consciously see invisible stimuli, which may help people with blindsight gain awareness. The study suggests a potential new line of research and treatments for acquired cortical blindness.
A new study uses bioluminescence imaging to detect eye tumors in vivo, enabling early treatment options that don't require surgery. The technology offers higher sensitivity and accuracy than traditional biopsy analysis, promising improved outcomes for patients.
Research highlights improved vision in type 1 diabetes patients, a link between macular degeneration and coronary heart disease, and the impact of vision on well-being across the lifespan. Effective treatments and better management of blood glucose levels contribute to the positive trend.
Researchers at Duke University Medical Center have developed a handheld device that uses SD OCT to create 3-D images of the retina, allowing for early detection of retinopathy of prematurity. The technology can snap pictures up to 40 times faster than previous versions and is being used to analyze data on over 20 infants.
A recent study has identified gene variants for glaucoma in a black population, which could lead to future treatments or a cure for the disease. The finding is significant as it explains nearly one-third of the genetic risk for glaucoma and could provide a more accurate and earlier diagnosis.
Researchers from the University of Florida and the University of Washington successfully used gene therapy to restore color vision in two squirrel monkeys. The study demonstrates the potential for this treatment to target adult vision disorders involving cone cells, a crucial step towards developing therapies for human cone diseases.
A study predicts a 40% increase in blindness in Nigeria by 2020, with nearly all cases being either preventable or treatable. The research found that cataracts, glaucoma, and refractive errors are the most common causes of blindness, particularly among those with limited access to healthcare.
GS-101 demonstrates significant inhibition and regression of corneal neovascularisation in a phase II study. The treatment is generally well-tolerated with no serious side effects, offering a new approach to managing ophthalmic angiogenesis.
A comprehensive review confirms the safety and efficacy of Descemet's Stripping Endothelial Keratoplasty (DSEK) as a treatment for corneal endothelial diseases, which affect 85% of corneal transplants in the US. In contrast, a type of antibiotic fluoroquinolone has been linked to double vision in some patients.
Researchers found that brain predicts what eyes in motion will see, even before they move, allowing for a stable visual environment despite retinal image shifts. This remapping process enables continuous representation of locations across eye movement, facilitating the transition between current and expected images.
Researchers have documented remarkable vision improvements in three young adults with Leber Congenital Amaurosis after receiving gene therapy. The patients continue to experience increased sensitivity to light, and one patient was able to read an illuminated clock for the first time at 1 year after treatment.
Researchers are exploring the use of anti-growth factor drugs to treat children's eye diseases, offering a new tool in the fight against vision loss. However, specialists warn that these drugs may pose serious side effects, particularly in young patients.
Researchers found that bevacizumab significantly improved vision in diabetic patients with macular edema, with 51.8% of eyes showing improvement after 24 months. Additionally, the treatment controlled cystoid macular edema after cataract surgery, with most eyes improving and remaining stable.
Dr. Haydee Bazan received a $710,000 grant from the National Institutes of Health to explore potential therapeutic approaches to heal corneal injuries. The research focuses on finding balance between signaling mechanisms that promote cellular damage or repair in the cornea.
A study published in Archives of Ophthalmology found that collagen copolymer lens implantation is effective in correcting moderate to high myopia over four years. The procedure has been shown to provide stable correction with minimal complications, but longer-term follow-up is necessary to assess potential late-onset issues.
Two studies published in the July issue of Ophthalmology highlight the connection between normal-tension glaucoma and silent cerebral infarcts, as well as stealthy herpes simplex infections impacting corneal transplants. Silent cerebral infarfts are more common among NTG patients and can lead to rapid visual field loss.
A recent study shows that telemedicine can diagnose retinopathy of prematurity faster than traditional bedside ophthalmoscopy. By reducing travel and communication time, telemedicine can improve the efficiency of care for ophthalmologists.
A study published in Investigative Ophthalmolgy & Visual Science found that multiple genetic, ocular, and environmental factors contribute to the incidence of AMD. Researchers developed a predictive model using these variables, which can be used to guide prevention and treatments.
A five-year study funded by the National Institutes of Health will examine the impact of cataract surgery on everyday life for people with dementia. Researchers aim to document how restored vision improves daily tasks and overall well-being.
Corneal transplant failures were found to be four times higher in patients with corneal edema or Fuchs' dystrophy compared to those without. Glaucoma patients who take medications alone have a 29% failure rate, highlighting the importance of adherence to treatment plans.
Dr. Andrew Tsin, a UTSA biologist, has been inducted into the Association for Research in Vision and Ophthalmology's inaugural class of fellows. He is recognized for his significant contributions to eye research, including studies on pigment regeneration and vascular endothelial growth factor secretion.
Two reports in Archives of Ophthalmology found that consuming omega-3 fatty acids from fish, nuts, and olive oil was associated with a lower risk of age-related macular degeneration. Eating one serving of fish per week reduced the risk by 31%, while consuming one to two servings of nuts lowered it by 35%.
Researchers have discovered a series of distinct concentric zones in gecko eyes that enable exceptional night vision, leading to potential advancements in camera technology and multifocal contact lenses. The study, published in the Journal of Vision, also introduces a new method for gathering optical data from live animals without harm.
The LUMINATE trials demonstrate the ability of LX211 to significantly improve chronic eye inflammation in patients with uveitis. The study results also show a safety profile for LX211, allowing it to be suitable for chronic use as the first oral treatment for this sight-threatening inflammatory eye disease.
A new study analyzed dietary factors and found that a combination of key nutrients and low-glycemic index foods can reduce age-related macular degeneration (AMD) risks. Additionally, research highlights the cost-effectiveness of glaucoma treatment in improving vision quality and quality of life.
A recent analysis found that downloads and citations are highly correlated with a 0.74 correlation coefficient, indicating that downloads can be used as an alternative metric to measure article impact. Downloads mirror citations but become available about two years earlier.
This year's Proctor Medal recipient, Joe G. Hollyfield, is recognized for his research on drusen and age-related macular degeneration. Samuel Wu receives the Friedenwald Award for pioneering retinal signaling process systems.
The Association for Research in Vision and Ophthalmology (ARVO) has announced its inaugural class of Fellows, honoring members who have made significant contributions to vision research and ophthalmology. The ARVO Fellow title recognizes outstanding achievements in leadership, collaboration, and dedication to advancing the field.
Four young researchers under 45 received the 2009 ARVO-AFER/Merck Innovative Ophthalmology Research Award for their groundbreaking research on glaucoma and back-of-the-eye diseases. The award recognizes outstanding investigative work that could lead to meaningful improvements in patients' lives.
The study found a 95.4% patient satisfaction rate for LASIK procedures, confirming its status as a successful elective surgery. In contrast, patients who used combined inhaled and oral steroids were found to have an elevated risk of developing cataracts, particularly posterior subcapsular cataract.
A study published in Ophthalmology found that while vision problems are rare among urban preschoolers, nearly 5% require treatment, yet only 1% receive it. Untreated refractive errors can lead to amblyopia and strabismus if left unchecked.
The school has received a record-breaking $1 million grant, including three individual awards totaling up to $925,000. The grants will support research into age-related macular degeneration, rhodopsin structure and function, and the pathogenesis of cataract and diabetic retinopathy.
Researchers are exploring various factors that contribute to glaucoma, including the role of glial cells, mitochondria, and immune response. The report highlights potential approaches for neuroprotection, such as targeting mitochondrial events and manipulating the immune system to repair neural tissue.
A new study published in Ophthalmology highlights the association between skin moles and freckles and a higher risk of uveal melanoma, while also reassuring on the low infection rates following cataract surgery. The research found that people with atypical moles are 2.8 times more likely to develop uveal melanoma.
Researchers discovered that optical illusions, like the Rotating Snakes illusion, activate the brain's motion-perception area, suggesting a bottom-up process rather than imagination. This finding has implications for designing instrument panels and multimedia content to avoid motion sickness.